GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioLASCO Taiwan Co Ltd (ROCO:6662) » Definitions » Market Cap

BioLASCO Taiwan Co (ROCO:6662) Market Cap : NT$934.8 Mil (As of Oct. 31, 2024)


View and export this data going back to 2018. Start your Free Trial

What is BioLASCO Taiwan Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). BioLASCO Taiwan Co's share price for the quarter that ended in Jun. 2024 was NT$36.9. BioLASCO Taiwan Co's Shares Outstanding (EOP) for the quarter that ended in Jun. 2024 was 25.6 Mil. Therefore, BioLASCO Taiwan Co's market cap for the quarter that ended in Jun. 2024 was NT$945.1 Mil.

BioLASCO Taiwan Co's quarterly market cap increased from Dec. 2023 (NT$850.3 Mil) to Mar. 2024 (NT$919.5 Mil) and increased from Mar. 2024 (NT$919.5 Mil) to Jun. 2024 (NT$945.1 Mil).

BioLASCO Taiwan Co's annual market cap declined from Dec. 2021 (NT$779.9 Mil) to Dec. 2022 (NT$764.5 Mil) but then increased from Dec. 2022 (NT$764.5 Mil) to Dec. 2023 (NT$850.3 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. BioLASCO Taiwan Co's Enterprise Value for Today is NT$895.4 Mil.


BioLASCO Taiwan Co Market Cap Historical Data

The historical data trend for BioLASCO Taiwan Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioLASCO Taiwan Co Market Cap Chart

BioLASCO Taiwan Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 977.10 904.10 779.89 764.52 850.32

BioLASCO Taiwan Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 796.53 831.11 850.32 919.47 945.08

Competitive Comparison of BioLASCO Taiwan Co's Market Cap

For the Biotechnology subindustry, BioLASCO Taiwan Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioLASCO Taiwan Co's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioLASCO Taiwan Co's Market Cap distribution charts can be found below:

* The bar in red indicates where BioLASCO Taiwan Co's Market Cap falls into.



BioLASCO Taiwan Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

BioLASCO Taiwan Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=NT$33.2*25.612
=NT$850.3

BioLASCO Taiwan Co's Market Cap for the quarter that ended in Jun. 2024 is calculated as

Market Cap (Q: Jun. 2024 )=Share Price (Q: Jun. 2024 )*Shares Outstanding (EOP) (Q: Jun. 2024 )
=NT$36.9*25.612
=NT$945.1

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioLASCO Taiwan Co  (ROCO:6662) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


BioLASCO Taiwan Co Market Cap Related Terms

Thank you for viewing the detailed overview of BioLASCO Taiwan Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


BioLASCO Taiwan Co Business Description

Traded in Other Exchanges
N/A
Address
3rd Floor, 316 Chong-yang Road, Taipei, TWN, 115
BioLASCO Taiwan Co Ltd is a biological experimental development company. The company has produced strains of laboratory rats and mice, including outbreed stocks, inbreed strains, and immunedeficient models. It offers reagent kit and equipment which include Allentown, Biomedical data system, PLAS LABS.

BioLASCO Taiwan Co Headlines

No Headlines